Pancreatic Cancer Research

ResearcherLanzhou UniversityActive in the last 2 years

Yanliang Chen

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-0475-3774; OpenAlex author ID A5066357555.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2024: 2 papers

Papers 2

  1. Radioresistance-related gene signatures identified by transcriptomics characterize the prognosis and immune landscape of pancreatic cancer patients. Last author DOI 10.1186/s12885-024-13231-4↗
  2. 14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway. Co-author DOI 10.18632/aging.205896↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Dandan Wang · 1 shared paper, 2024
  2. Qiuning Zhang · 1 shared paper, 2024
  3. Dandan Wang · 1 shared paper, 2024

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.